MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Tarsus Pharmaceuticals, Inc. Common Stock

TARS

#1395
Tarsus Pharmaceuticals, Inc. Common Stock
75.5200
+1.46%
Sector:
Base:
Profit Currency:
Daily Range
75.5200
75.5200
Year Range
60.5400
85.2500
Daily Change
+1.46%
Monthly Change
+11.06%
6 month change
+14.32%
Year Change
+14.32%
Previous Close
74.4350
Open
75.5200
Bid
Ask
Low
75.5200
High
75.5200
Volume
74
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. TARS
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

News

Investor's Business Daily Investor's Business Daily
UI STRL HROW STOK TARS
yesterday, 17:58
These Growth Stocks Form Classic Cup Bases. Here's Where To Buy.
Investor's Business Daily Investor's Business Daily
ASML NVT KEYS HUT MSFT
2 days ago, 00:11
ASML, With Unique AI Tech, Leads 8 Hot Growth Stocks Joining IBD's Top Screens
Investor's Business Daily Investor's Business Daily
ROAD FNV AEM EQX TARS
2026.02.24
Construction Star Leads 11 Hot Stocks To Various Best Growth Lists like IBD 50, Sector Leaders
Investing Investing
BAC-PS HSIC AAPL WFC HD
2026.02.24
AMD, IBM among market cap stock movers on Tuesday
Investing Investing
TARS
2026.02.24
Tarsus earnings missed by $0.12, revenue topped estimates
Seeking Alpha Seeking Alpha
TARS
2026.02.24
Tarsus Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:TARS) 2026-02-23
Zacks Zacks
TARS MIRM
2026.02.24
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates
Investing Investing
TARS
2026.02.23
Earnings call transcript: Tarsus Pharmaceuticals Q4 2025 sees robust growth
Investing Investing
TARS
2026.02.23
Tarsus faces earnings test as losses narrow, revenue surges
Zacks Zacks
MIRM TARS
2026.02.18
Mirum Pharmaceuticals, Inc. (MIRM) Earnings Expected to Grow: What to Know Ahead of Q4 Release
Investing Investing
TARS
2026.02.18
Former Allergan CEO David Pyott joins Tarsus Pharmaceuticals board
Zacks Zacks
TARS
2026.02.17
Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd